Annual Changes to the NASDAQ Biotechnology Index
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Celgene (CELG) Takes 5% Stake in Oncomed (OMED)
December 16, 2013 2:24 PM ESTIn a 13G filing on Oncomed Pharmaceuticals (Nasdaq: OMED), Celgene Corp (Nasdaq: CELG) disclosed a 5.00%, or 1,470,588 share, stake in the company. The percentage is based upon 29,384,647 outstanding shares of Common Stock of Oncomed as of December 2, 2013.
... More
